IQVIA

Biotech in post-Brexit Britain: the future for the UK’s pharma-innovation engine?

https://pharmaphorum.com/views-and-analysis/biotech-in-post-brexit-britain-the-future-for-the-uks-pharma-innovation-engine/

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

https://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/

UCB, Roche, and IQVIA take lead in UK life sciences investment

https://pharmaphorum.com/news/ucb-roche-and-iqvia-take-lead-in-uk-life-sciences-investment/

Can simulated datasets unlock the potential of patient data?

https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/

Realising the biotech promise: addressing the path to market

https://pharmaphorum.com/market-access-2/addressing-the-path-to-market/

How to win at omnichannel

https://pharmaphorum.com/partner-content/enabling-omnichannel-strategy-a-single-platform-for-content-management/

IQVIA Launches ePromo – a new Commercial Content Management Solution

https://pharmaphorum.com/partner-content-sales-marketing/iqvia-launches-epromo-a-new-commercial-content-management-solution/

Report warns of UK’s rare disease ‘postcode lottery’

https://pharmaphorum.com/news/report-warns-of-rare-disease-postcode-lottery/

Could digital technology revolutionise pharma in 2018?

https://pharmaphorum.com/views-and-analysis/digital-technology-revolutionise-pharma-2018/

1 2

Close in 10 seconds

Pharmaphorum.com

Search